These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 1677232

  • 1. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T, Brown KW, Woods JP.
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.
    Brown KW, White T.
    Biol Psychiatry; 1991 Dec 15; 30(12):1182-90. PubMed ID: 1686411
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR, Liddle PF, Curson DA, Patel M.
    Br J Psychiatry Suppl; 1989 Nov 15; (7):99-103. PubMed ID: 2575915
    [No Abstract] [Full Text] [Related]

  • 8. Akathisia variants and tardive dyskinesia.
    Barnes TR, Braude WM.
    Arch Gen Psychiatry; 1985 Sep 15; 42(9):874-8. PubMed ID: 2864031
    [Abstract] [Full Text] [Related]

  • 9. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B, Mester R, Abesgaus J, Wittenberg N, Adlersberg S, Gonen N, Weizman A.
    J Clin Psychiatry; 1997 Jul 15; 58(7):318-22. PubMed ID: 9269253
    [Abstract] [Full Text] [Related]

  • 10. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.
    Weiden PJ, Mann JJ, Haas G, Mattson M, Frances A.
    Am J Psychiatry; 1987 Sep 15; 144(9):1148-53. PubMed ID: 2888321
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
    Tugg LA, Desai D, Prendergast P, Remington G, Reed K, Zipursky RB.
    Schizophr Res; 1997 May 03; 25(1):71-8. PubMed ID: 9176929
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tardive dyskinesia as a risk factor for negative symptoms.
    Taylor SJ.
    Br J Psychiatry; 1994 May 03; 164(5):701-2. PubMed ID: 7921732
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Handedness as a risk factor for neuroleptic-induced movement disorders.
    Brown KW, White T, Anderson F, McGilp R.
    Biol Psychiatry; 1992 Apr 01; 31(7):746-8. PubMed ID: 1350923
    [No Abstract] [Full Text] [Related]

  • 18. Movement disorders and psychological tests of frontal lobe function in schizophrenic patients.
    Brown KW, White T, Palmer D.
    Psychol Med; 1992 Feb 01; 22(1):69-77. PubMed ID: 1349440
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN, Matroos GE, Hoek HW, Kahn RS.
    Schizophr Res; 1996 May 01; 19(2-3):195-203. PubMed ID: 8789918
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.